See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070336_2018_Achillion_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001070336, Achillion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 303,938,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,816,000 |
| 3 | remainder_Assets | 30,859,000 |
| 4 | LiabilitiesCurrent | 12,884,000 |
| 5 | LiabilitiesNoncurrent | 131,000 |
| 6 | remainder_Liabilities | 83,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,580,907 |
| 9 | ResearchAndDevelopmentExpense | 66,342,547 |
| 10 | remainder_Expenses | 46,043 |
| 11 | remainder_Revenues | 4,250,406 |
| 12 | remainder_NetIncome | 7,239,423 |
| 13 | remainder_ComprehensiveNetIncome | 195,999 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 337,613,000 |
| 1 | Liabilities | 13,098,000 |
| 2 | Expenses | 90,969,497 |
| 3 | Revenues | 4,250,406 |
| 4 | StockholdersEquity | 324,515,000 |
| 5 | NetIncome | -79,479,668 |
| 6 | ComprehensiveNetIncome | -79,381,668 |
| 7 | BaseVar | 226,683,162 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.58 |
| 9 | EconomicCapitalRatio | 4.09 |
Edgar->Model Mapping
Feature Distribution
Change over Time
